The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
Abstract
With increasing numbers of immune-compromised patients with malignancy, hematologic disease, and HIV, as well as those receiving immunosupressive drug regimens for the management of organ transplantation or autoimmune inflammatory conditions, the incidence of fungal infections has dramatically increased over recent years. Definitive diagnosis of pulmonary fungal infections has also been substantially assisted by the development of newer diagnostic methods and techniques, including the use of antigen detection, polymerase chain reaction, serologies, computed tomography and positron emission tomography scans, bronchoscopy, mediastinoscopy, and video-assisted thorascopic biopsy. At the same time, the introduction of new treatment modalities has significantly broadened options available to physicians who treat these conditions. While traditionally antifungal therapy was limited to the use of amphotericin B, flucytosine, and a handful of clinically available azole agents, current pharmacologic treatment options include potent new azole compounds with extended antifungal activity, lipid forms of amphotericin B, and newer antifungal drugs, including the echinocandins. In view of the changing treatment of pulmonary fungal infections, the American Thoracic Society convened a working group of experts in fungal infections to develop a concise clinical statement of current therapeutic options for those fungal infections of particular relevance to pulmonary and critical care practice. This document focuses on three primary areas of concern: the endemic mycoses, including histoplasmosis, sporotrichosis, blastomycosis, and coccidioidomycosis; fungal infections of special concern for immune-compromised and critically ill patients, including cryptococcosis, aspergillosis, candidiasis, and Pneumocystis pneumonia; and rare and emerging fungal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–262 of 262
Toon, S., Ross, C. E., Gokal, R., & Rowland, M. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03623.x · Cited by 76
Successful Treatment of Cerebral Blastomycosis with Voriconazole
Bakleh, M., Aksamit, A. J., Tleyjeh, I. M., & Marshall, W. F. (2005) · Clinical Infectious Diseases · doi:10.1086/429319 · Cited by 76
Efficacy of Voriconazole in Treatment of Murine Pulmonary Blastomycosis
Sugar, A. M., & Liu, X. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.601-604.2001 · Cited by 75
Connolly, P., Wheat, J., Schnizlein-Bick, C. T., Durkin, M., Kohler, S., Smedema, M. L., Goldberg, J. S., Brizendine, E. J., & Loebenberg, D. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.322 · Cited by 75
Saccente, M., Abernathy, R. S., Pappas, P. G., Shah, H. R., & Bradsher, R. W. (1998) · Clinical Infectious Diseases · doi:10.1086/clinids/26.2.413 · Cited by 74
Verweij, P. E., Mensink, M., Rijs, A., Donnelly, J. P., Meis, J. F. G. M., & Denning, D. W. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.3.389 · Cited by 74
Chronic Necrotizing Pulmonary Aspergillosis: Pathologic Outcome After Itraconazole Therapy
Caras, W. E., & Pluss, J. L. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.1.25 · Cited by 73
Popp, A. I., White, M. H., Quadri, T., Walshe, L., & Armstrong, D. (1999) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(99)90038-3 · Cited by 71
King, M. D., Perlino, C. A., Cinnamon, J., & Jernigan, J. A. (2002) · International Journal of STD & AIDS · doi:10.1258/095646202760326516 · Cited by 69
Micafungin: A New Echinocandin Antifungal
Joseph, J., Jain, R., & Danziger, L. H. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.1.53 · Cited by 69
In vitro susceptibility of Cryptococcus gattii clinical isolates
Gómez‐López, A., Zaragoza, Ó., Martins, M. D. A., Melhem, M. D. S. C., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02021.x · Cited by 69
Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model
Mody, C. H., Toews, G. B., & Lipscomb, M. F. (1988) · Infection and Immunity · doi:10.1128/iai.56.1.7-12.1988 · Cited by 69
Self-citationMacsween, K. F., Bicanic, T. A., Brouwer, A. E., Marsh, H. T., Macallan, D. C., & Harrison, T. S. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.02.010 · Cited by 68
Armengou, A., Porcar, C., Mascaró, J. M., & Garcia-Bragado, F. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.6.1337-a · Cited by 68
Intracavitary aspergilloma: transthoracic percutaneous injection of amphotericin gelatin solution.
Munk, P. L., VELLET, A. D., Rankin, R. N., et al. (1993) · Radiology · doi:10.1148/radiology.188.3.8351355 · Cited by 66
Successful Treatment of Disseminated Nonmeningeal Coccidioidomycosis with Voriconazole
Prabhu, R. M., Bonnell, M. R., Currier, B. L., & Orenstein, R. (2004) · Clinical Infectious Diseases · doi:10.1086/424019 · Cited by 66
Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen
Borgia, S. M., Fuller, J. D., Sarabia, A., & El‐Helou, P. (2006) · Medical Mycology · doi:10.1080/13693780600803870 · Cited by 65
Acute Respiratory Failure Associated With Pulmonary Cryptococcosis in Non-AIDS Patients
Vilchez, R. A., Linden, P., Lacomis, J. M., Costello, P., Fung, J. J., & Kusne, S. (2001) · CHEST Journal · doi:10.1378/chest.119.6.1865 · Cited by 65
Efficacy of SCH56592 in a Rabbit Model of Invasive Aspergillosis
Kirkpatrick, W. R., McAtee, R. K., Fothergill, A. W., Loebenberg, D., Rinaldi, M. G., & Patterson, T. F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.780-782.2000 · Cited by 64
Friese, G., Discher, T., Füssle, R., Schmalreck, A., & Lohmeyer, J. (2001) · AIDS · doi:10.1097/00002030-200111230-00026 · Cited by 64
Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis
Greenberger, P. A. (1994) · Allergy and Asthma Proceedings · doi:10.2500/108854194778816463 · Cited by 63
Vilchez, R. A., Irish, W. D., Lacomis, J. M., Costello, P., Fung, J. J., & Kusne, S. (2001) · Medicine · doi:10.1097/00005792-200109000-00004 · Cited by 63
The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis
Seaton, R. A., Verma, N., Naraqi, S., Wembri, J. P., & Warrell, D. A. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90393-x · Cited by 61
Corticosteroids for Blastomycosis-Induced ARDS
Lahm, T., Neese, S., Thornburg, A., Ober, M. D., Sarosi, G. A., & Hage, C. A. (2008) · CHEST Journal · doi:10.1378/chest.07-2778 · Cited by 60
Self-citationLiliang, P., Liang, C.-L., Chang, W. ‐., Chen, H.-J., Su, T.-M., Lu, K., & Lu, C.-H. (2003) · Clinical Infectious Diseases · doi:10.1086/377208 · Cited by 60
Diamond, D. M., Bauer, M., Daniel, B. E., Leal, M. A. E., Johnson, D. L., Williams, B. K., Thomas, A., Ding, J. C., Najvar, L. K., Graybill, J. R., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.528 · Cited by 60
Nivoix, Y., Ubeaud-Séquier, G., Engel, P., Levêque, D., & Herbrecht, R. (2009) · Current Drug Metabolism · doi:10.2174/138920009788499012 · Cited by 59
Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis
Imai, J. K., Singh, G., Clemons, K. V., & Stevens, D. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.4063-4066.2004 · Cited by 59
Self-citationUsefulness of Inhaled High-dose Corticosteroids in Allergic Bronchopulmonary Aspergillosis
Imbeault, B., & Cormier, Y. F. (1993) · CHEST Journal · doi:10.1378/chest.103.5.1614 · Cited by 56
Parker, J. D., Sarosi, G. A., Doto, I. L., BAILEY, R. E., & Tosh, F. E. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007302830503 · Cited by 56
Self-citationT., B., W., F., H., B., N., B., K.-H., D., M., H., D., H., U., J., G., J.-N., M., K., et al. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0730-4 · Cited by 53
Azole Drug Resistance as a Cause of Clinical Relapse in AIDS Patients with Cryptococcal Meningitis
Birley, H., Johnson, E. M., McDonald, P., Parry, C. M., Carey, P. B., & Warnock, D. W. (1995) · International Journal of STD & AIDS · doi:10.1177/095646249500600510 · Cited by 51
The treatment of pulmonary aspergilloma.
Judson, M. A., & Stevens, D. A. (2001) · PubMed · Cited by 49
Self-citationRambeloarisoa, J., Batisse, D., Thiébaut, J.-B., Mikol, J., Mrejen, S., Karmochkine, M., Kazatchkine, M. D., Weiss, L., & Piketty, C. (2002) · Journal of Infection · doi:10.1053/jinf.2001.0955 · Cited by 47
Pulmonary Manifestations of Cryptococcosis in Patients with AIDS
Sider, L., & Westcott, M. A. (1994) · Journal of Thoracic Imaging · doi:10.1097/00005382-199421000-00004 · Cited by 46
Allergic bronchopulmonary aspergillosis: a retrospective study of 35 cases.
Behera, D., Guleria, R. S., Jindal, S. K., Chakrabarti, A., & Panigrahi, D. (1994) · PubMed · Cited by 46
Sabbatani, S., Manfredi, R., Pavoni, M., Consales, A., & Chiodo, F. (2004) · Mycopathologia · doi:10.1023/b:myco.0000041904.71381.e3 · Cited by 45
Antifungal prophylaxis for invasive mycoses in high risk patients
Ullmann, A. J., & Cornely, O. A. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3280108e45 · Cited by 45
Combined treatment: antifungal drugs with antibodies, cytokines or drugs
Stevens, D. A., Kullberg, B. J., Brummer, E., Casadevall, A., Netea, M. G., & Sugar, A. M. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.305.315 · Cited by 45
Self-citationClark, B., Foster, R., Tunbridge, A., & Green, S. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.01.001 · Cited by 44
Treatment of Murine Cryptococcosis with Cyclosporin-A in Normal and Athymic Mice
Mody, C. H., Toews, G. B., & Lipscomb, M. F. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.1.8 · Cited by 44
Self-citationRecurrent Blastomycosis of the Central Nervous System: Case Report and Review
Chowfin, A., Tight, R. R., & Mitchell, S. (2000) · Clinical Infectious Diseases · doi:10.1086/313828 · Cited by 38
Seaton, A., Seaton, R. A., & Wightman, A. J. A. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068964 · Cited by 38
Ketoconazole Metamorphosis: An Antimicrobial Becomes an Endocrine Drug
Stevens, D. A. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.5.813 · Cited by 37
Self-citationFluconazole in the Treatment of Persistent Coccidioidomycosis
Catanzaro, A., Fierer, J., & Friedman, P. J. (1990) · CHEST Journal · doi:10.1378/chest.97.3.666 · Cited by 37
Self-citationHofhuis, J. G. M., Bakker, J., Schultz, M. J., Rommes, J. H., & Spronk, P. E. (2003) · CHEST Journal · doi:10.1378/chest.124.6.2143 · Cited by 37
Barcia, J. P. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03915.x · Cited by 35
Chaskes, S., Frasés, S., Cammer, M., Gerfen, G. J., & Casadevall, A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01721-07 · Cited by 35
Advances against Aspergillosis
Steinbach, W. J., Stevens, D. A., Denning, D. W., & Moss, R. B. (2003) · Clinical Infectious Diseases · doi:10.1086/376522 · Cited by 33
Self-citationAlves, S. H., Lopes, J. O., Costa, J. M., & Klock, C. (1997) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46651997000600010 · Cited by 30
Groll, A. H., Renz, S., Gerein, V., Schwabe, D., Katschan, G., Schneider, M., Hiibner, K., & Kornhuber, B. (1992) · Mycoses · doi:10.1111/j.1439-0507.1992.tb00822.x · Cited by 29
Blankenship, J. R., Singh, N., Alexander, B. D., & Heitman, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.464-467.2005 · Cited by 29
Pulmonary resection for localized lesions of cryptococcosis (torulosis): a review of eight cases.
Smith, F. S., Gibson, P., Nicholls, T. T., & Simpson, J. A. (1976) · Thorax · doi:10.1136/thx.31.2.121 · Cited by 28
Antifungal compounds: controversies, queries and conclusions
Graybill, J. R., Tollemar, J. G., Torres-Rodríguez, J. M., Walsh, T. J., Roilides, E., & Farmaki, E. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.323.333 · Cited by 28
Immunotherapy for invasive fungal infections: from bench to bedside
Pappas, P. G. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2003.12.002 · Cited by 28
Zhao, Q., Wojcik, M. A., Parier, J., & Pesco‐Koplowitz, L. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.2.149.34109 · Cited by 25
Current pharmacotherapy of allergic bronchopulmonary aspergillosis
Judson, M. A., & Stevens, D. A. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.7.1065 · Cited by 25
Self-citationMurine models of blastomycosis, coccidioidomycosis, and histoplasmosis
Sorensen, K. N., Clemons, K. V., & Stevens, D. A. (1999) · Mycopathologia · doi:10.1023/a:1007081707287 · Cited by 20
Self-citationPulmonary Cryptococcosis Presenting with Multiple Pulmonary Nodules
Zlupko, G. M., Fochler, F. J., & Goldschmidt, Z. H. (1980) · CHEST Journal · doi:10.1378/chest.77.4.575 · Cited by 18
Cook, P. (2001) · Southern Medical Journal · doi:10.1097/00007611-200194050-00026 · Cited by 16
Zellweger, C., Opravil, M., Bernasconi, E., Cavassini, M. L., Bucher, H. C., Schiffer, V., Wagels, T., Flepp, M., Rickenbach, M., & Furrer, H. (2004) · AIDS · doi:10.1097/00002030-200410210-00009 · Cited by 15
Chandrasekar, P. H. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705563 · Cited by 4
Cited by
Pulmonary aspergillosis: a clinical review
Kousha, M., Tadi, R., & Soubani, A. O. (2011) · European Respiratory Review · doi:10.1183/09059180.00001011 · Cited by 752
Galgiani, J. N., Ampel, N. M., Blair, J. E., Catanzaro, A., Geertsma, F., Hoover, S. E., Johnson, R. H., Kusne, S., Lisse, J., MacDonald, J. D., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw360 · Cited by 622
Self-citationLimper, A. H., Adenis, A., Le, T., & Harrison, T. S. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30303-1 · Cited by 472
Self-citationColonization by Pneumocystis jirovecii and Its Role in Disease
Morris, A., & Norris, K. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-12 · Cited by 429
Pulmonary cryptococcosis: A review of pathobiology and clinical aspects
Setianingrum, F., Rautemaa-Richardson, R., & Denning, D. W. (2019) · Medical Mycology · doi:10.1093/mmy/myy086 · Cited by 289
Metadata
- Authors
- Limper, A. H., Knox, K. S., Sarosi, G. A., Ampel, N. M., Bennett, J. E., Catanzaro, A., Davies, S. F., Dismukes, W. E., Hage, C. A., Marr, K. A., Mody, C. H., Perfect, J. R., & Stevens, D. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-01-01
- Volume
- 183
- Issue
- 1
- Pages
- 96-128
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2146153570
- Cited by
- 612
- References
- 262
- FWCI
- 13.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.